These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8394448

  • 41. Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo.
    Ludert JE, Feng N, Yu JH, Broome RL, Hoshino Y, Greenberg HB.
    J Virol; 1996 Jan; 70(1):487-93. PubMed ID: 8523562
    [Abstract] [Full Text] [Related]

  • 42. Characterization of neuraminidase-resistant mutants derived from rotavirus porcine strain OSU.
    López JA, Maldonado AJ, Gerder M, Abanero J, Murgich J, Pujol FH, Liprandi F, Ludert JE.
    J Virol; 2005 Aug; 79(16):10369-75. PubMed ID: 16051829
    [Abstract] [Full Text] [Related]

  • 43. Proteolytic enhancement of human rotavirus infectivity.
    Konno T, Suzuki H, Kitaoka S, Sato T, Fukuhara N, Yoshie O, Fukudome K, Numazaki Y.
    Clin Infect Dis; 1993 Mar; 16 Suppl 2():S92-7. PubMed ID: 8384014
    [Abstract] [Full Text] [Related]

  • 44. Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry.
    Aoki ST, Trask SD, Coulson BS, Greenberg HB, Dormitzer PR, Harrison SC.
    J Virol; 2011 Oct; 85(20):10509-17. PubMed ID: 21849465
    [Abstract] [Full Text] [Related]

  • 45. Role of sialic acids in rotavirus infection.
    Isa P, Arias CF, López S.
    Glycoconj J; 2006 Feb; 23(1-2):27-37. PubMed ID: 16575520
    [Abstract] [Full Text] [Related]

  • 46. Identification of a new VP4 serotype of human rotaviruses.
    Gerna G, Sears J, Hoshino Y, Steele AD, Nakagomi O, Sarasini A, Flores J.
    Virology; 1994 Apr; 200(1):66-71. PubMed ID: 8128639
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Rotavirus-induced fusion from without in tissue culture cells.
    Falconer MM, Gilbert JM, Roper AM, Greenberg HB, Gavora JS.
    J Virol; 1995 Sep; 69(9):5582-91. PubMed ID: 7637004
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
    Li Y, Xue M, Yu L, Luo G, Yang H, Jia L, Zeng Y, Li T, Ge S, Xia N.
    Vaccine; 2018 Apr 12; 36(16):2086-2092. PubMed ID: 29555220
    [Abstract] [Full Text] [Related]

  • 55. Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype.
    Coulson BS, Kirkwood C.
    J Virol; 1991 Nov 12; 65(11):5968-74. PubMed ID: 1656083
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Group C rotavirus requires sialic acid for erythrocyte and cell receptor binding.
    Svensson L.
    J Virol; 1992 Sep 12; 66(9):5582-5. PubMed ID: 1380096
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.